Evidence map›Paper›PMID 31344785›Full record

ReviewMolecules (Basel, Switzerland)2019

An Updated Review on Pharmaceutical Properties of Gamma-Aminobutyric Acid.

Dai-Hung Ngo, Thanh Sang Vo

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed
42.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 407 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effect of Oral Administration ofInternational journal of environmental research and public health · 2022
    Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Probiotic properties and functional potential of high-GABABiochemistry and biophysics reports · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Can bacteria control the human brain?Communicative & integrative biology · 2026
    Review

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dai-Hung NgoFaculty of Natural Sciences, Thu Dau Mot University, Thu Dau Mot City 820000, Vietnam.
Thanh Sang VoNTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City 700000, Vietnam. vtsang@ntt.edu.vn.
Dalat University · VNTrường ĐH Nguyễn Tất Thành · VN

Funding

National Foundation for Science and Technology Development 106.02-2018.304
6 · The paper itself

Abstract

Gamma-aminobutyric acid (Gaba) is a non-proteinogenic amino acid that is widely present in microorganisms, plants, and vertebrates. So far, Gaba is well known as a main inhibitory neurotransmitter in the central nervous system. Its physiological roles are related to the modulation of synaptic transmission, the promotion of neuronal development and relaxation, and the prevention of sleeplessness and depression. Besides, various pharmaceutical properties of Gaba on non-neuronal peripheral tissues and organs were also reported due to anti-hypertension, anti-diabetes, anti-cancer, antioxidant, anti-inflammation, anti-microbial, anti-allergy, hepato-protection, reno-protection, and intestinal protection. Therefore, Gaba may be considered as potential alternative therapeutics for prevention and treatment of various diseases. Accordingly, this updated review was mainly focused to describe the pharmaceutical properties of Gaba as well as emphasize its important role regarding human health.

Indexed as

AnimalsAntihypertensive AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic Agentsgamma-Aminobutyric AcidHumansHypoglycemic AgentsNervous System DiseasesNeuroprotective AgentsNeurotransmitter AgentsAntihypertensive AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic Agentsgamma-Aminobutyric AcidHypoglycemic AgentsNeuroprotective AgentsNeurotransmitter Agentsanti-hypertensionbioactivityGabaGaba-rich producthealth benefit

Identifiers

PMID31344785
PMCPMC6696076
OpenAlexW2964193653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.